Investors Urged to Join ModivCare Inc. Securities Fraud Class Action Lawsuit

Attention ModivCare Investors: Join the Class Action

In a significant development for shareholders of ModivCare Inc. (NASDAQ: MODV), the Rosen Law Firm is reaching out to investors who purchased securities of the company between November 3, 2022, and September 15, 2024, to inform them of an important opportunity to participate in a class action lawsuit concerning securities fraud. With a lead plaintiff deadline set for March 31, 2025, now is the time for affected investors to act.

What’s at Stake?

The class action lawsuit is premised on allegations that during the outlined class period, ModivCare’s management made materially false statements and failed to reveal critical information about the company's business performance and prospects. In particular, internal issues with contracts in its non-emergency medical transportation (NEMT) segment led to a decline in its free cash flow, impacting everything from adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) to liquidity issues.

When this unflattering information came to light, investors reportedly incurred significant losses. Being a part of this litigation could enable affected individuals to seek compensation for their losses without upfront legal costs due to a contingency fee arrangement — where payment is only made upon a successful outcome.

How to Get Involved

To join the ModivCare class action lawsuit, investors should visit the Rosen Law Firm's dedicated webpage here, or they can contact Phillip Kim, Esq. toll-free at 866-767-3653. Additionally, interested parties can reach out via email at [email protected] for further clarification on the class action and details on how to proceed.

It’s noteworthy that although a class action lawsuit has already been filed, a designated class has yet to be certified. This means that until such certification occurs, investors are advised to seek representation in this matter actively. Class members may also choose to remain passive, but their ability to partake in potential recoveries will depend on their engagement in the process.

Why Choose Rosen Law Firm?

The Rosen Law Firm has established itself as a reputable entity in the realm of securities litigation. With an impressive track record, including the largest-ever settlement for a securities class action involving a Chinese company, the firm has become a prominent advocate for investor rights globally. It has consistently ranked highly for its number of settlements, recovering substantial amounts for its clients. Founding partner Laurence Rosen's recognition as a leading figure in securities law further underscores their expertise.

Moreover, many staff attorneys at Rosen Law Firm have been recognized by platforms like Lawdragon and Super Lawyers for their outstanding performance in the field.

The Timeline for Investors

As investors deliberate on their next steps, it’s vital to remember the impending March 31, 2025, cutoff date for appointing a lead plaintiff in the case. A lead plaintiff not only represents their own interests but also those of other class members, playing a pivotal role in guiding the litigation process.

In conclusion, for any investor who has purchased ModivCare securities during the specified period, participating in this lawsuit could be a crucial step towards seeking fairness and accountability. The actions taken now could hold significant implications for the investor community. Don't miss out on this opportunity; join today!

For more updates and information about this ongoing matter, follow Rosen Law Firm on their social media platforms: